Webinar recordings

Part 1: Use of QCI Interpret to elucidate precision in breast cancer targeted therapy

216 views
October 24, 2016
Breast cancer is a complex heterogeneous disease, with each subtype characterised by distinct clinical features and molecular alterations. The heterogeneity of breast cancer has presented massive challenges for identifying appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond stratification of patients by hormone receptor and epidermal growth factor receptor status. QIAGEN Clinical Insight Interpret is a web-based application for the annotation, classification, and reporting of actionable variants from NGS data in clinical genomics laboratories.

Related videos

Webinar recordings

QIAGEN Clinical Insight (QCI) Interpret identifies targeted therapy and clinical trials in...

312 views December 08, 2016

Hematological malignancies originating from hematopoietic and lymphoid tissue...

Webinar recordings

Detect low frequency variants from targeted DNA panels, with high accuracy

264 views November 09, 2016

In this webinar we demonstrate how to analyze unique molecular indices (UMIs)...